How Frank was paid
$1.4M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Morgan FrankChief Executive Officer | $4 | — | $1,383,842 | — | $1,383,846 |
| Andrew WalkoPresident | $230,000 | — | $909,230 | — | $1,139,230 |
| Nanci Gilmoreformer Chief Commercial Officer | $225,000 | $65,000 | $636,462 | $7,200 | $933,662 |
What changed and why
- $1.4M$1,383,846 was Morgan Frank’s total 2024 compensation, including $1,383,842 in option awards.
- $4$4 was Morgan Frank’s 2024 salary, increased from a de minimis $1 annual salary.
- $1.1M$1,139,230 was Andrew Walko’s total 2024 compensation, including $909,230 in option awards.
- $934K$933,662 was Nanci Gilmore’s total 2024 compensation, including a $65,000 discretionary bonus.
- 2024 board fees were changed to option awards instead of cash fees.
- 50%50% of annual bonus incentives is based on individual goals and the remainder on Company performance measures.
Other Sanuwave Health proxy statements
- 2026 proxy statement
Morgan Frank paid $414,087 (-70% on the year).
Filed Apr 29, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.